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The impact of mixture spectra deconvolution on the performance of four popular de novo
sequencing programs was tested using artificially constructed mixture spectra as well as ex-
perimental proteomics data. Mixture fragmentation spectra are recognized as a limitation in
proteomics because they decrease the identification performance using database search en-
gines. De novo sequencing approaches are expected to be even more sensitive to the reduction
in mass spectrum quality resulting from peptide precursor co-isolation and thus prone to false
identifications. The deconvolution approach matched complementary b-, y-ions to each precur-
sor peptide mass, which allowed the creation of virtual spectra containing sequence specific
fragment ions of each co-isolated peptide.Deconvolution processing resulted in equally efficient
identification rates but increased the absolute number of correctly sequenced peptides. The
improvement was in the range of 20–35% additional peptide identifications for a HeLa lysate
sample. Some correct sequences were identified only using unprocessed spectra; however, the
number of these was lower than those where improvement was obtained by mass spectral
deconvolution. Tight candidate peptide score distribution and high sensitivity to small changes
in the mass spectrum introduced by the employed deconvolution method could explain some
of the missing peptide identifications.
Keywords:
Bioinformatics / Complementary ions / De novo sequencing / Mass spectral interfer-
ence / Mixture fragmentation spectra
 Additional supporting information may be found in the online version of this article atthe publisher’s web-site
1 Introduction
The most common method of analyzing proteomics data in-
volves searching against protein sequence databases (Uniprot
[1], NCBI GenBank [2], etc.) that accumulate protein and ge-
netic information from numerous experimental sources [1].
Bioinformatics programs were developed to correlate exper-
imental data with database information include MASCOT
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Abbreviations: LD, Levenshtein distance; MWCO, molecular
weight cutoff; PSM, peptide-spectrum match; SNP, single nu-
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[3], SEQUEST [4], OMSSA [5], X!Tandem [6], and MS-GF+
[7]. Although protein database searching has become reliable
and routine in proteomics, it suffers from some shortcom-
ings [8]. First, protein sequences in the databases can be
incomplete due to the absence of data from some biologi-
cal species or chemical modifications of the proteins such
as post-translational modifications (PTMs) [9]. Second, most
eukaryotic proteins undergo alternative splicing of genes and
may be subject to single nucleotide polymorphisms (SNPs)
or amino acid mutations resulting in creation of proteoforms
[10]. Finally, only a portion of a known database sequence is
used, e.g. the sequence is limited to certain biological species
and proteinmodifications; therefore, some errors are possible
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Significance of the study
De novo sequencingmethods are popular for reliable proteo-
form recognition and detection of pointmutations in protein
sequences that are crucial for truly personalized medicine.
Wider application of de novo approaches requires high data
quality. Improvements to the de novo sequencing software
or data handling, therefore, should be of interest to the
proteomics community. We hope that this study will raise
awareness of the challenge of mixture fragmentation spec-
tra introduced to data analysis. We demonstrated that bet-
ter handling of mixture fragmentation spectra provided not
only higher quality data but also increased the depth of the
analysis.
if the sample contains proteins and peptides from other bio-
logical species and/or any unexpected PTMs [11].
De novo sequencing might be considered to be the most
efficient method for protein sequencing because it allows
deduction of peptide sequences directly from mass spectra
not limited to database size. Most modern de novo sequenc-
ing programs convert the mass spectrum into a spectrum
graph where the optimal path in this graph represents the
peptide sequencing results [12, 13] obtained by dynamic pro-
gramming [14–17] or integer linear programming [18, 19].
Probabilistic modeling [20], machine learning techniques
[21, 22], composition restriction by accurate mass measure-
ments [23, 24], divide-and-conquer [25], or linear sequencing
algorithms [26,27] are othermethods used. Somewell-known
programs are SHERENGA [12], Lutefisk [28], NovoHMM [20],
PEAKS [16], PepNovo [29], and pNovo [30].
De novo sequencing approaches have recently received
more attention due to the growing availability of highmass ac-
curacy instrumentation [31]. The best de novo algorithms are
orders of magnitude faster than the fastest database search
engines when used on large databases, however, they are less
accurate [32]. Thus, the most advanced modern sequencing
software is reported to correctly determine peptide sequences
in 30–50% of the mass spectra [13, 32, 33]. The limited ac-
curacy stems from incomplete series of sequence specific
fragments often masked by peaks generated from various
interferences [34]. In addition, peptides with similar frag-
mentation spectra (“homeometric peptides”) [35] add to the
sequencing complexity. Thus, selection of peptide relevant
product ions and other methods of spectra processing used
before de novo sequencing are important and several meth-
ods have been proposed specifically for this task [36, 37].
Mixture fragmentation spectra produced by simultaneous
fragmentation of several co-isolated peptide precursors are
recognized by the proteomics community as a limitation in
shotgun proteomics. Mixture spectra decrease the identifica-
tion performance of database search engines [38–41]. De novo
sequencing approaches are expected to be evenmore sensitive
to the quality of the fragmentation spectrum and thus more
prone to errors caused by peptide precursor co-isolation. For
the algorithms used for protein sequence database search-
ing, the risk of misidentification is not as dramatic, particu-
larly for protein targets without PTMs, because the search
space of actual protein sequences is smaller than the set
of sequences that can be theoretically generated [42]. We
previously reported on a data processing approach capable
of deconvolution of mixture spectra using the principle of
b-, y-ion complementarity [40, 41]. Here, we investigated the
impact of mixture spectra on the performance of commonly
used de novo sequencing programs and evaluated the appli-
cability of our approach to assist de novo sequencing. Given
the diversity of de novo sequencing programs, we focused
our comparison on the data processing, rather than bench-
marking the programs.
2 Materials and methods
Extended experimental details can be found in the Supporting
information.
2.1 HeLa cell lysate preparation and analysis
The human cervix epithelial adenocarcinoma (HeLa) cell
lysate was prepared as published earlier [40], excluding the
dimethyl labeling step. The lysate was chromatographically
separated using a Dionex (Thermo, USA) Ultimate 3000
nanoUPLC system, coupled to an Orbitrap Fusion (Thermo
Scientific, CA, USA) mass spectrometer. Peptides were frag-
mented using CID in the linear ion trap and analyzed in Or-
bitrap. Data analysis was performed using Thermo Proteome
Discoverer 2.0.0.802, MASCOT 2.3 as the database search
engine, and Percolator 2.05 [43] to validate peptide-spectrum
matches (PSMs).
2.2 Tityus serrulatus venom sample
Collection and preparation of T. serrulatus venom was de-
scribed previously [44]. The lysate was separated using a Prox-
eon EASY nanoHPLC system coupled to an Orbitrap Velos
Pro mass spectrometer (Thermo Scientific, CA, USA). Ions
were isolated and fragmented using CID in the linear ion trap
followed by Orbitrap detection.
2.3 Artificial mixture spectra creation
All datamanipulation was performed using developed scripts
in Python (v. 2.7.6). High-quality PSMs with unique se-
quenceswere selected fromHeLa cell lysate analysis and used
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to form 5000 artificial mixture spectra each consisting of two
merged peptide fragment spectra having the absolute differ-
ence between parent ions mass-to-charge values less than
one unit. Mimicking data-dependent acquisition experiment,
one fragment spectrum of each peptide pair was considered
target and another contaminating peptide (target peptide cor-
responds to the peptide targeted/selected by the mass spec-
trometer for fragmentation, while contaminant peptide cor-
responds to the peptide sharingmass and time space with the
target one, though not selected by the mass spectrometer as
the progenitor of the fragmentation spectrum). Correspond-
ing spectra were cleaned of any interfering peaks and mixed
preserving total ion intensity with the following mixture ra-
tios between targets and contaminating peptides: 0.001, 0.01,
0.05, 0.1, 0.25, 0.5, 0.75, 0.9, 0.95, 0.99, and 0.999. Spectra
were saved in MASCOT generic format for further process-
ing. In addition, the data set having 50% mixture and 50%
non-mixture spectra was created. Additional details could be
found in Extended Materials and Methods and Fig. S1 of the
Supporting Information.
2.4 Mixture spectra deconvolution
Mixture spectra deconvolution was performed as reported
earlier [40]. Proteome Discoverer was used for mass spectra
processing. First, spectra were charge deconvoluted (all ions
singly charged) using MSn Deconvolution node followed by
mixture spectra deconvolution using Complementary Finder
node. For complete HeLa lysate and scorpion samples, con-
sidered masses for co-isolated peptides were required to have
peptide mass peaks in the corresponding parent mass spec-
trum, and no restrictions (e.g., intensity, member of an iso-
topic cluster, etc.) were applied to the mass peak. All masses
for co-isolated peptides were accepted during the analysis of
artificial mixture spectra. Typical processing time on a regu-
lar benchtop computer was less than a minute for artificial
mixture spectra and scorpion samples and under 10 min
for complete HeLa lysate. Mixture spectra deconvolution re-
sulted in the generation of two additional spectra files for
each input file. The first (purified spectra) contained only
target spectra excluded from contaminating fragments, ex-
tracted co-isolated spectra were not added to the resulting
file. The second (deconvoluted spectra) contained concate-
nated purified and extracted spectra.
2.5 De novo sequencing
The following programs were used for de novo sequenc-
ing: PEAKS (v7.0 build 20140912) [16], pNovo+ (v1.3) [30],
pepNovo+ (v3.1 release 20101117) [29, 35, 45, 46] and Novor
(v1.1) [47]. The following parameters were used for all pro-
grams: parent mass tolerance – 10 ppm; fragment mass
tolerance – 0.02 Da; enzyme – trypsin; carbamidomethy-
lated cysteine and oxidized methionine as fixed and variable
modifications, respectively. PEAKS specific parameters: max
variable PTMs per peptide – 3; number of report peptides – 5.
pNovo+ specific parameters: activation type – CID; mini-
mal precursor mass – 300 Da; maximal precursor mass –
5000 Da. pepNovo+ specific parameters: precursor mass tol-
erance – 0.02 Da (pepNovo+ support only absolute tolerance
for parent mass); no quality filter; model – CID_IT_TRYP;
use spectrum precursor m/z and charge. The following score
thresholds were used: PEAKS ALC > 66; pNovo+ Score >
30; Novor aaScore > 36 and no threshold for pepNovo+.
Score thresholds were empirically determined and normal-
ized to provide the closest possible accuracy of each de novo
sequencing program. More details can be found in Extended
Materials and Methods (Supporting information).
2.6 Database search of artificial mixture spectra
The following parameters were used by MASCOT (v. 2.3.2)
and SequestHT (as included in Proteome Discoverer): parent
mass tolerance – 10 ppm; fragment mass tolerance – 0.02 Da;
enzyme – trypsin, full specificity;maximummissed cleavages
– 2; carbamidomethylated cysteine and oxidized methionine
as fixed and variable modifications, respectively.
3 Results and discussion
3.1 Comparison of mixture spectra impact on de
novo and database sequencing
Artificially created mixture spectra served as an initial as-
sessment of the effect of mixture spectra on de novo se-
quencing (see Extended Materials and Methods (Supporting
Information) for preparation details). The formed datasets
were analyzed by PEAKS de novo in comparison to database
searching with MASCOT and SequestHT. By construction,
we knew true sequences of the peptides forming each spec-
trum, which allowed for measurement of unbiased true iden-
tification rates. Those data are plotted in Fig. 1 for 11 tested
mixture ratios. True identification rates were calculated as the
fraction of all reported peptide sequences that matched either
the target peptide sequence or the contamination peptide se-
quence. It is known that several common errors can occur
during de novo sequencing, for example, isoelement substi-
tutions (glutamine with glycine-alanine pair and asparagine
with glycine-glycine) [48]. Each of these errors produces se-
quences with Levenshtein distance (LD) [49] of not more than
two from the original sequence, therefore, LD 2 mismatch
between the reference and reported sequences was allowed.
Increasingmixture ratio lowered the performance of the de
novomethod drastically, although database searching was in-
sensitive formixture ratios up to 0.95. By contrast,Houel et al.
[38] reported a reduction in true identification rate from 1.0 to
0.86 at 0.5 mixture ratio using database searching. Note that,
first, mass spectra in this study were of very high quality and
C© 2016 The Authors. Proteomics Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Figure 1. True identification rate and the number of true identifications at different mixture ratios for de novo (PEAKS) and database
searching (MASCOT and SequestHT). Cutoff: IonsScore > 13 (MASCOT), XCorr > 1.0 (SequestHT), ALC > 66 (de novo); LD  2.
free of any interference which is not typical for proteomics
datasets and, second, search parameters were limited using
prior knowledge of the mass spectral construction. From
Fig. 1, the de novo sequencing was more affected by the pres-
ence of mixture fragmentation spectra; moreover, it is critical
to achieve as high true identification rate as possible, because
erroneous sequences require more effort to eliminate in the
context of de novo sequencing.
3.2 De novo sequencing of artificial mixture spectra:
accuracy
Mixture spectra were processed using MSn Deconvolution
and Complementary Finder nodes [40]. As a result, two ad-
ditional spectra sets were created, the first (referenced as
“purified”), contained spectra purified from any detected co-
isolated fragments, and the second (referenced as “deconvo-
luted”) contained concatenated purified spectra and extracted
spectra of all detected co-isolated peptides. Figure 2 illus-
trates the performance of PEAKS de novo depending on the
mixture ratio. Elimination of contaminating fragments from
targetmass spectra (purified spectra) resulted in an enhanced
true identification rate formixture ratios below 0.95 (Fig. 2A).
Performance degraded only for extreme mixture rates
(>0.95), which might be due to the very low quality of the
target component. For the deconvoluted datasets, the true
identification rates were relatively constant for all mixture ra-
tios. Again, some degradation in performance was observed
for extreme ratios (<0.01 and >0.99) that could be explained
by low ion abundance (low quality) of one of the extracted
spectra, which increased the total number of reported peptide
sequences, but could not provide enoughmass spectral infor-
mation for reliable sequence identification. Erroneously ex-
tracted spectrawhenno co-isolationwas present could also re-
duce true identification rates. Nevertheless, the total number
of correct identifications (Fig. 2B) after deconvolution was
higher than that found in the purified and mixture datasets.
The same analysis was performed for three other de novo
sequencing programs (Supporting Information Fig. S3). To
account for differences in scoring algorithms used by each
program, we applied normalization of score cutoffs using a
standard dataset (refer to Extended Materials and Methods
and Fig. S2 in the Supporting Information for details). In
spite of normalization, the observed performance still varied
between programs indicating more fundamental differences
among them.However, the overall trend in true identification
rates was similar to that observed earlier: mixture spectra de-
convolution produced constantly high accuracy independent
of mixture rate. The number of true identifications followed
the trend similar to PEAKS (Fig. 2B) for all programs, except
for pNovo+. The latter delivered more identifications from
unprocessed data compared to deconvoluted one for mixture
rates lower than 0.25. This type of performance could proba-
bly be explainedby the characteristics of this specific program;
moreover pNovo+ delivered the smallest absolute number of
identifications among all programs, thus score cutoff might
be too restrictive.
3.3 De novo sequencing of artificial mixture spectra:
number of identifications
A comparison of correctly identified sequences at different
mixture ratios is displayed in Fig. 3. Notably, the number
of peptide sequences identified in the deconvoluted dataset
increased with mixture ratio and reached the greatest abso-
lute improvement at the mixture ratio of 0.95. The overlap
between the results obtained for the mixture and deconvo-
luted datasets was high; however, at all mixture ratios, a small
portion of the correct sequences was found only in the mix-
ture dataset. This portion was as high as 5–6% at small and
C© 2016 The Authors. Proteomics Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Figure 2. (A) True identification rate and (B) number of correct identifications for different processing of artificial mixture spectra. PEAKS
ALC > 66; LD  2.
medium mixture rates (0.001 – 0.75) and reached 10–12%
at mixture ratios > 0.95. It is expected that for some tan-
dem mass spectra several possible sequences might obtain
very similar scores, thus, some small differences in the spec-
trum (presence or absence of neutral loss peak) might favor
one over others. These unintended changes could be intro-
duced by the employed mixture spectrum deconvolution al-
gorithm. However, for all mixture ratios the deconvoluted
spectra resulted in a higher number of additionally identified
sequences, which was achieved with better reliability (higher
true identification rate).
The occurrence of mixture spectra in shotgun proteomics
experiments is a function of both sample complexity and
isolation capability of the mass spectrometer applied. How-
ever, recent reports [38, 39] showed that about 50% of mix-
ture spectra are expected. We, therefore, created an artificial
dataset containing 50%mixture spectra to simulate these con-
ditions in a de novo setting. In total, 1881 correct sequences of
2311 sequences above the ALC threshold were obtained from
the unprocessed dataset. In comparison, we found 2577 cor-
rect sequences of 3048 sequences above the ALC threshold
for the deconvoluted dataset. This translated to success rates
of 81 and 85% for unprocessed and deconvoluted datasets, re-
spectively. These results demonstrated that the technique of
mixture spectra deconvolution did not impair correct peptide
sequence identification. Hence, deconvolution led to a larger
Figure 3. Number of correct
sequences identified in artifi-
cial mixture spectra before and
after mixture spectra decon-
volution (PEAKS; ALC > 66).
Red: sequences identified only
in the deconvoluted dataset,
blue: sequences identified only
in the mixed dataset, purple:
sequences identified in both
datasets.
C© 2016 The Authors. Proteomics Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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absolute number of true identifications due to the interro-
gation of 37% more spectra. Similar to earlier observations,
about 5% (83) of the correct sequences belonged solely to
the unprocessed spectra; however, nearly one order of mag-
nitude higher number of correct sequences (778) identified
only from deconvoluted spectra compensated for this loss in
identified peptides. Most sequences (1798) were identified by
both processing methods.
3.4 De novo sequencing of HeLa cell lysate: accuracy
Encouraged by the results obtained with the artificially gener-
ated mixture spectra, we tested our deconvolution technique
on the entire dataset of experimentally obtained CIDMS/MS
spectra from a HeLa lysate. Unlike the artificial dataset, this
dataset included spectra with various abundances, noise lev-
els, and non-canonical fragments that complicate the de novo
sequencing. Because it is important in de novo sequencing
to have high spectral quality, we applied an additional fil-
ter for the mixture deconvolution processing. Considered
co-isolated peptide masses were required to have a corre-
sponding peak in the parent spectrum (see Materials and
Methods). The original spectrum file contained 137 893 MS2
spectra, which were converted to 215 362 MS2 spectra after
processing; thus, the number of extracted spectra was close
to the expected number of co-isolations in a typical shotgun
experiment (50%) [39].
Each tandem mass spectrum file was analyzed sepa-
rately by de novo sequencing programs and resulting se-
quences were compared between unprocessed, purified tar-
get, and deconvoluted spectra. Since the exact peptide iden-
tity of each fragmentation spectrum cannot be known,
and, therefore, true identification rate cannot be measured
directly, the human protein database concatenated with
common contaminants was used to estimate it. However,
not all de novo derived sequences absent in the database
were falsely identified and, vice versa, even if an identi-
fied peptide exists in the database the fragmentation spec-
trum it was deduced from could have been produced by
some other peptide. Details of database validation could be
found in the Extended Materials and Methods (Support-
ing Information). Table 1 contains information on the valid
identification rates, as a ratio between sequencing results
producing valid (present in the database) sequences and the
total number of reported sequences above the score cutoff.
The largest valid identification rate was observed for the puri-
fied spectra, whereas smaller rates were found for the mixed
and deconvoluted spectra. Valid identification rates for de-
convoluted spectra were slightly higher than for unprocessed
data for PEAKS and pNovo+ and at the same level for Novor.
The only exception was pepNovo+, where deconvolution re-
sulted in lower valid identification rate. The latter observation
can be explained by the fact, that we did not apply any score
threshold for pepNovo+ results, in order to normalize its
performance to the other programs.
Table 1. Valid identification rate by different processing of HeLa
lysate sample
Program Valid identification rate
Unprocessed
(%)
Purified
(%)
Deconvoluted
(%)
PEAKS 46.18 49.80 47.58
pNovo+ 45.63 52.59 51.74
pepNovo+ 56.01 58.60 44.70
Novor 45.66 47.94 45.42
Novor aaScore > 36; pNovo+ Score > 30; PEAKS ALC > 66;
pepNovo+ no restriction
At large, this suggests that our data processing eliminated
some spectral interferences and improved the data quality
of purified target spectra. However, co-isolated spectra are
expected to have limited ion statistics and, as the conse-
quence, lower mass spectral quality, therefore, the overall
performance decreases for the deconvoluted spectra.
3.5 De novo sequencing of HeLa cell lysate: number
of identifications
Only valid sequences were used to compare different process-
ing methods. Both unprocessed and deconvoluted datasets
resulted in largely the same peptide identifications (overlap
> 80%), although the number of additional peptide identifica-
tions increased after deconvolution (Fig. 4). Similar to earlier
observations, some valid sequences could only be found in
the unprocessed dataset (ranging from 10 to 20% depend-
ing on de novo program employed). The observed increase
in the number of sequences identified solely in the unpro-
cessed dataset was expected due to lower data quality of many
extracted peptide spectra. Again, pNovo+ was an exception
with fewer identified sequences from deconvoluted data, al-
though with a clear improvement in accuracy.
The difference in valid identification rate and number of
peptide identifications was observed between the tested de
novo sequencing programs (Table 1 and Fig. 4), which is in
alignment with the results found for the artificial mixture
dataset. However, for all programs, except pNovo+, improve-
ment in the number of correct sequences with little to no
degradation in sequencing accuracy was observed by apply-
ing mixture spectra deconvolution.
3.6 De novo sequencing of T. serrulatus
Re-analysis of the venom of scorpion T. serrulatus served as
a test of our deconvolution approach with a sample of un-
known protein/peptide composition. Two samples were pre-
pared. One sample consisted of a non-digested lowmolecular
mass fraction (10 000 MWCO) and another sample consisted
of a high molecular mass fraction of venom digested with
C© 2016 The Authors. Proteomics Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Figure 4. Number of valid sequences identified by different processing of HeLa lysate sample. Novor aaScore > 36; pNovo+ Score > 30;
PEAKS ALC > 66; pepNovo+ no restriction. Red: sequences identified only in the deconvoluted dataset, blue: sequences identified only in
the mixed dataset, purple: sequences identified in both datasets.
trypsin: these samples are referenced as peptides and pro-
teins, respectively. Because lowermolecular complexity of the
scorpion samples compared to the HeLa lysate sample was
anticipated, we decided to analyze these samples by HPLC-
MS/MS-CID with a short analytical gradient of 10 min in
an attempt to retain realistic co-isolation rate. Fig. 5 displays
the number of identified sequences from unprocessed and
deconvoluted datasets.
Deconvolution of mixture spectra typically resulted in
some increase in the number of identified peptide sequences.
As previously observed, the magnitude of the effect was dif-
ferent between de novo sequencing programs: for PEAKS
the increase in peptide identification reached 13%, and little
to no improvement was observed for other programs. The
primary explanation for this might be found in the diversity
in the sequencing algorithms and scoring schemes used by
each program. For example, pepNovo+ uses fragmentation
model trained on a large number of real spectra, however,
the spectra produced after the deconvolution might not ful-
fill the assumptions of the model well. However, the results
observed in the analysis of the HeLa sample were different;
therefore, the explanationmight also include the nature of the
sample and employed instrumentation. In particular, the
sample complexity was different between the two biological
samples. Obviously, the effect of mixture spectra deconvolu-
tion was limited for less complex samples. This is in line with
a lower number of extracted spectra for each input spectrum
(0.12 and 0.28 for peptide and protein samples, respectively).
The same number was 0.56 for the HeLa sample. Moreover,
lower mass spectral quality and/or higher de novo sequenc-
ing complexity of non-tryptic peptides was expected. Because
tryptic peptides have a basic residue (lysine or arginine) at
their C-termini, they tend to produce more informative frag-
ments than the non-tryptic peptides. The overlap between un-
processed and deconvoluted spectra was similar to the anal-
ysis of HeLa lysate for the protein sample and lower than
expected for the peptide sample. The opposite observation
was made for the number of sequences identified only in the
unprocessed sample. Although there were no solid criteria
to validate resulting sequences, it was expected that the true
identification rate was lower for non-tryptic peptides, which
explained both observations.
Figure 5. Number of sequences
identified in scorpion samples.
Novor aaScore > 36; pNovo+
Score > 30; PEAKS ALC > 66;
pepNovo+ no restriction. Red:
sequences identified only in de-
convoluted dataset, blue: se-
quences identified only inmixed
dataset, purple: sequences iden-
tified in both datasets. All identi-
fied sequences reportedwithout
validation.
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Verano-Braga et al. [44] reported 317 peptides from 1225
different sequence tags, matching known genes of Tityus sp.
detected by PEAKS (ALC > 70) in the peptide fraction of
the venom. Our analysis detected 116 sequences of which
41 could be assigned to proteins of Tityus sp. (103 sequences
matched 40proteinswithout deconvolution) at the same score
threshold. Observed numbers were less, however, because
we used only CID fragmentation rather than a combination
of CID, ETD, and HCD used in the above-mentioned study
[44]. The repertoire of functional classes observed herein
was close to that observed by Verano-Braga et al. and in-
cluded Hypotensins and Hypotensin-like peptide, Pape pep-
tide, and several potassium channel toxins. The only protein
not present in the earlier report [44] was Venom Peptide 7
(P86828), which was identified with the single high scoring
peptide (RLRSKG) in unprocessed and deconvoluted datasets
(ALC 93 and ALC 96, respectively).
4 Concluding remarks
High data quality is one of the crucial requirements for
successful de novo sequencing. The presence of peptide co-
isolation adds to the spectral complexity and hence it is de-
sirable to develop efficient methods for mixture spectra de-
convolution. Although programs to analyze mixture spectra
are available [50–53], they have not yet been evaluated in
the context of de novo sequencing. Using artificial mixture
spectra with various mixture ratios, we demonstrated that
the true identification rate was affected by the presence of co-
isolated fragments in themass spectrum, particularly for high
mixture ratios. The observed degradation was more promi-
nent, compared to database searchmethods, due to the larger
search space tested by de novo approaches. Mixture spectra
deconvolution was tested in combination with four de novo
sequencing programs on three different datasets. The pro-
posed deconvolution technique resulted in the identification
of more peptide sequences without compromising the identi-
fication rates. The employed deconvolution approach was not
without limitations and further improvement could make
this technique even more efficient. In particular, a smaller
fraction of correct peptide sequences was only identified in
unprocessed datasets. Some of these missing identifications
could be explained by the tight score distribution of candi-
date sequences resulting in high sensitivity to small changes
in the mass spectrum introduced by the employed deconvo-
lution method. For the venom samples of T. serrulatus, only
a moderate increase in the number of detected sequences
was observed. Insufficient sample complexity resulting in a
low number of co-isolations and less informative fragmenta-
tion of non-tryptic peptides might be the primary reasons for
the observed effect, the latter of which could be improved by
advancing de novo sequencing programs.
With this study we hope to raise awareness of the chal-
lenge that mixture fragmentation spectra introduces to data
analysis. Wider application of de novo approaches dictated
by the growing interest in the study of protein variants, non-
sequenced proteins, the presence of unusual protein modifi-
cations, and deeper proteome interrogation requires higher
data quality. More efficient data handling of mixture frag-
mentation spectra provides not only higher quality data but
increases the depth of analysis. The employedmixture spectra
deconvolution technique uses a basic principle of fragment
complementarity to detect and separate co-isolated peptides.
We believe that its performance can be further improved by
incorporation of other principles, for example, retention time
alignment or advanced noise suppression.
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